Evaluation of Machine-Learning Algorithms for Predicting Opioid Overdose Risk Among Medicare Beneficiaries With Opioid Prescriptions.
Wei-Hsuan Lo-Ciganic, James L Huang, Hao H Zhang...
https://pubmed.ncbi.nlm.nih.gov/30901048Actively Recruiting
Led by University of Pittsburgh · Updated on 2026-03-20
1350
Participants Needed
1
Research Sites
N/A
Total Duration
U
University of Pittsburgh
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
Researchers are evaluating a clinician-targeted behavioral nudge intervention embedded in the Electronic Health Record (EHR) to help identify patients at higher risk for opioid overdose using a machine-learning based risk prediction model. This trial aims to improve opioid prescribing safety and reduce overdose risk by comparing usual care to enhanced care with flags and behavioral nudges for clinicians in primary care settings. The study includes three groups: one receiving usual care without changes, one with an elevated-risk flag displayed in the EHR during patient encounters, and one with the flag combined with best practice alerts or behavioral nudges triggered under specific conditions. These nudges encourage safer prescribing, such as prescribing naloxone or providing justification for high opioid doses or overlapping prescriptions. Participants are patients who have received an opioid prescription and visited a primary care practice in the last year. Researchers will assess prescribing practices at 4 and 6 months after enrollment, including measures like naloxone prescriptions, opioid dosage, and overlapping medications. The study will monitor emergency department or inpatient visits for overdose and overall visits to evaluate the intervention's impact on patient safety and prescribing behavior.
CONDITIONS
Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or telephone)
Duration - Up to 6 months following enrollment
Participants receive care at primary care practices where clinicians may see an elevated-risk flag for opioid overdose during in-person or telephone encounters. Some participants’ clinicians will also receive behavioral nudges to encourage safer prescribing practices.
Visits occur during routine primary care encounters as needed
Total: 1 location
1
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15213
Actively Recruiting
L
Lead Research Program Coordinator, CP3
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Wei-Hsuan Lo-Ciganic, James L Huang, Hao H Zhang...
https://pubmed.ncbi.nlm.nih.gov/30901048Wei-Hsuan Lo-Ciganic, James L Huang, Hao H Zhang...
https://pubmed.ncbi.nlm.nih.gov/32678860Wei-Hsuan Lo-Ciganic, Julie M Donohue, Eric G Hulsey...
https://pubmed.ncbi.nlm.nih.gov/33735222Wei-Hsuan Lo-Ciganic, Julie M Donohue, Qingnan Yang...
https://pubmed.ncbi.nlm.nih.gov/35623798Jingchuan Guo, Walid F Gellad, Qingnan Yang...
https://pubmed.ncbi.nlm.nih.gov/35315173Walid F Gellad, Qingnan Yang, Kayleigh M Adamson...
https://pubmed.ncbi.nlm.nih.gov/37001323Khoa Nguyen, Debbie L Wilson, Julie Diiulio...
https://pubmed.ncbi.nlm.nih.gov/39420438Laura G Militello, Julie Diiulio, Debbie L Wilson...
https://pubmed.ncbi.nlm.nih.gov/39569464Walid F Gellad, Yi-Fan Chen, Tae Woo Park...
https://pubmed.ncbi.nlm.nih.gov/42081274